Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
Xconomy
FEBRUARY 13, 2020
The FDA said Thursday that its request for removal of the product from the market is voluntary, but Eisai has already started the process for doing so. Lorcaserin was approved in 2012 as a weight management therapy for use in addition to a reduced-calorie diet and exercise.
Let's personalize your content